Observe Medical ASA (STU:OM50) ROCE %: -91.40% (As of Dec. 2025)


STU:OM50 Observe Medical ASA STU:OM50
30 GF Score
Price €0.09
GF Value €0.02
! 5 Warning Signs
View Full Analysis

What is Observe Medical ASA ROCE %?

Observe Medical ASA STU:OM50 -3.40% 30 ROCE % is -91.40% as of Dec. 2025. GuruFocus rates STU:OM50 with a GF Score™ of 30/100 and a GF Value™ of €0.02. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Observe Medical ASA's annualized ROCE % for the quarter that ended in Dec. 2025 was -91.40%.

Observe Medical ASA  (STU:OM50) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Observe Medical ASA ROCE % Related Terms

Observe Medical ASA ROCE % Historical Data

* Premium members only.

The historical data trend for Observe Medical ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Observe Medical ASA ROCE % Chart

Observe Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -62.16 -65.59 -94.94 -49.70 -62.03

Observe Medical ASA Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.45 -37.10 -47.61 -40.92 -91.40
STU:OM50
30GF Score
Observe Medical ASA STU:OM50
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Observe Medical ASA ROCE % Calculation

Observe Medical ASA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-3.673/( ( (12.141 - 5.096) + (8.548 - 3.751) )/ 2 )
=-3.673/( (7.045+4.797)/ 2 )
=-3.673/5.921
=-62.03 %

Observe Medical ASA's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-4.794/( ( (11.516 - 5.823) + (8.548 - 3.751) )/ 2 )
=-4.794/( ( 5.693 + 4.797 )/ 2 )
=-4.794/5.245
=-91.40 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -91.40% mean?
Observe Medical ASA (STU:OM50) has a ROCE % of -91.40% as of Dec. 2025.
Is Observe Medical ASA's ROCE % too high?
Observe Medical ASA's current ROCE % is -91.40%. Overall, Observe Medical ASA has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Observe Medical ASA's ROCE % compare to ABT and SYK?
Observe Medical ASA's ROCE % of -91.40% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Observe Medical ASA's current ROCE % is -91.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Observe Medical ASA stock overvalued right now?
Observe Medical ASA (STU:OM50) has a current ROCE % of -91.40%. The stock's GF Value™ is €0.02, compared to a current price of €0.09 — trading 355% above its estimated fair value. The current ROCE % is -91.40%. Observe Medical ASA's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Observe Medical ASA (STU:OM50), the current ROCE % is -91.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Observe Medical ASA (STU:OM50) Overvalued in 2026?

Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued. The current stock price of €0.09 is trading 355% above its estimated GF Value™ of €0.02.

Key valuation signals for STU:OM50:

  • ROCE %: -91.40%
  • GF Value™: €0.02 vs. price of €0.09 (355% above fair value)
  • GF Score™: 30/100 with 5 warning signs

No single metric tells the full story. See the STU:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Observe Medical ASA Business Description

Other Exchanges OBSRV:NorwayOM50:Germany
Address Dronning Eufemias gate 16, Oslo, NOR, 0191
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
30GF Score

Get the complete analysis for STU:OM50

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.02
GF Value